Cargando…
A Rapid LC-MS/MS-PRM Assay for Serologic Quantification of Sialylated O-HPX Glycoforms in Patients with Liver Fibrosis
Development of high throughput robust methods is a prerequisite for a successful clinical use of LC-MS/MS assays. In earlier studies, we reported that nLC-MS/MS measurement of the O-glycoforms of HPX is an indicator of liver fibrosis. In this study, we show that a microflow LC-MS/MS method using a s...
Autores principales: | Panigrahi, Aswini, Benicky, Julius, Wei, Renhuizi, Ahn, Jaeil, Goldman, Radoslav, Sanda, Miloslav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000230/ https://www.ncbi.nlm.nih.gov/pubmed/35408612 http://dx.doi.org/10.3390/molecules27072213 |
Ejemplares similares
-
A multiplexed microflow LC–MS/MS-PRM assay for serologic quantification of IgG N- and HPX O- glycoforms in liver fibrosis
por: Panigrahi, Aswini, et al.
Publicado: (2023) -
Increased sialylation of site specific O-glycoforms of hemopexin in liver disease
por: Sanda, Miloslav, et al.
Publicado: (2016) -
Analysis of site and structure specific core fucosylation in liver cirrhosis using exoglycosidase-assisted data-independent LC-MS/MS
por: Sanda, Miloslav, et al.
Publicado: (2021) -
Identification and Relative Quantification of hFSH Glycoforms in Women’s Sera via MS–PRM-Based Approach
por: Melchiorre, Chiara, et al.
Publicado: (2021) -
Quantification of Fucosylated Hemopexin and Complement Factor H in Plasma
of Patients with Liver Disease
por: Benicky, Julius, et al.
Publicado: (2014)